Cardiff Oncology, Inc. Common Stock (CRDF) is a publicly traded Healthcare sector company. As of September 2, 2026, CRDF trades at $1.05 with a market cap of $77.30M and a P/E ratio of -1.10. CRDF moved +0.00% today. Year to date, CRDF is -61.28%; over the trailing twelve months it is -47.18%. Its 52-week range spans $0.76 to $4.99. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces CRDF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CRDF, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.05 |
| Market Cap | $77.30M |
| P/E Ratio | -1.10 |
| EPS | $-0.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.99 |
| 52-Week Low | $0.76 |
| Volume | 26.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $488.00K |
| Net Income | $-41.44M |
| Gross Margin | 0.00% |
6 analysts cover CRDF: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.